Post-authorisation, multi-centre, retrospective study to analyse the efficacy and safety of combination with trabectedin and pegylated liposomal doxorubicin (PLD) for the treatment of patients with platinum-sensitive, recurrent ovarian cancer (ROC), in accordance with the data sheet.
Investigador principal en Hospital Universitario Quirón Dexeus: Dr. Alejandro Martínez.
Center: Hospital Universitari Dexeus
Pathology: Cáncer ovario
Fundación QuirónsaludThe purpose of the Quirónsalud Foundation is to promote health and the habits of healthy living through social action, education and the management and promotion of research, aimed at patients, associations of patients, their families and society in general.